Psoriasis and Seasonality: Exploring the Genetic and Epigenetic Interactions.

Psoriasis is a multifactorial, chronic, and inflammatory disease that severely impacts patients' quality of life. The disease is caused by genetic irregularities affected by epigenetic and environmental factors. Some of these factors may include seasonal changes, such as solar radiation, air pollution, and humidity, and changes in circadian rhythm, especially in the temporal and polar zones.

Does the effectiveness of biological medications in the treatment for psoriasis depend on the moment of starting therapy? A preliminary study.

Introduction: It is well known that biological medications acting on selected elements of the immune response are highly effective in psoriasis treatment. It is a common perception that psoriasis is a seasonal disorder with improvement in warmer months, however it has not been unequivocally confirmed. It is not known whether the time of year of starting systematic therapy for psoriasis influences treatment outcomes.

Measurements of biologically effective solar radiation using erythemal weighted broadband meters.

In this paper, we describe conversion factors (CF) for the calculation of biologically effective irradiances (BEI) from erythemal irradiance for three effects: photosynthesis of previtamin D3, psoriasis healing, and inactivation of the SARS-Cov-2 virions. CFs were empirically derived from measurements of spectral solar ultraviolet (UV) radiation during all sky conditions at four mid-latitude sites in the Northern Hemisphere, namely Aosta, Belsk, Reading, and San Diego. These CFs were found to depend on solar zenith angle (SZA) and total column ozone, but are largely independent (within ± 5% for SZA < 60°) of local conditions such as surface albedo, visibility and other local atmospheric patterns.

Exposure to solar UV radiation of Polish teenagers after the first COVID-19 lockdown in March-April 2020.

In Poland, schools were closed from March to June 2020 due to the COVID-19 epidemic. During the lockdown (March-April), everyone was advised to stay at home. From May, students were allowed to spend time outdoors.

A Priori Estimation of the Narrow-Band UVB Phototherapy Outcome for Moderate-to-Severe Psoriasis Based on the Patients' Questionnaire and Blood Tests Using Random Forest Classifier.

Background: Nowadays, patients with moderate-to-severe psoriasis are treated with conventional immunosuppressants or with new biological agents. Phototherapy is the first-line treatment for patients in whom topical therapy is insufficient. Although numerous studies have been carried out, it is still difficult to predict the outcome of phototherapy in individual patients.